Login Register
English
0

Cart

$ 0

Unlocking Apoptotic Insights: The Definitive Guide to Cleaved-Caspase-9 p35 (D315) Polyclonal Antibody (ABP50010)

Date:2026-03-05 Views:77

Precision Detection of the Active Initiator
The Cleaved-Caspase-9 p35 (D315) Polyclonal Antibody (ABP50010) from Abbkine is a critical tool for researchers dissecting the intrinsic apoptotic pathway. This antibody specifically targets the p35 fragment generated by cleavage at aspartic acid 315 (D315), a hallmark event in the activation of Caspase-9. Unlike antibodies that detect the full-length proenzyme, ABP50010 provides a direct readout of the active, cleaved form, making it indispensable for distinguishing between latent and committed apoptotic states in cells. Its high specificity ensures minimal cross-reactivity with other caspases, offering clean Western blot bands and reliable immunohistochemistry staining .

Beyond the Apoptosome: A Key to Mitochondrial Feedback
While Caspase-9 is classically known for its role in the apoptosome complex, recent research underscores its function in a critical feedback loop. Upon activation, Caspase-9 not only cleaves downstream effectors like Caspase-3 but also targets anti-apoptotic BCL-2 family members. This cleavage of BCL-2, BCL-xL, and MCL-1 by active Caspase-9 disrupts mitochondrial integrity, amplifying the apoptotic signal. The ABP50010 antibody is essential for validating this feedback mechanism, as it specifically detects the active enzyme responsible for this mitochondrial disruption, a process crucial for full commitment to cell death .

Technical Excellence and Broad Application Spectrum
Formulated as a rabbit polyclonal antibody, ABP50010 is affinity-purified for high specificity and low background noise. It is validated for multiple applications, including Western Blot (recommended dilution 1:500-1:2000), Immunohistochemistry (IHC), and Immunofluorescence (IF). The antibody exhibits reactivity with human, mouse, and rat samples, making it a versatile choice for cross-species studies. Its ability to detect the 35 kDa p35 fragment with high sensitivity makes it a go-to reagent for quantifying apoptotic induction in cancer research, neurobiology, and developmental studies .

Strategic Insights for Apoptosis Research
In the evolving landscape of cell death research, the ability to accurately measure initiator caspase activation is paramount. The Cleaved-Caspase-9 p35 (D315) Polyclonal Antibody (ABP50010) provides researchers with a robust tool to probe not just the initiation of apoptosis but also the complex regulatory feedback that governs mitochondrial permeability. Its specificity for the D315 cleavage site makes it a superior choice for studies investigating the subtle dynamics of Caspase-9 activation in response to DNA damage, chemotherapeutic agents, or developmental cues .